Cardiff reveals early data on challenger to Amgen’s KRAS crown
Cardiff reveals early data on challenger to Amgen’s KRAS crown [...]
Obsidian bags $115M to untether cell therapy from toxic sidekick
Obsidian bags $115M to untether cell therapy from toxic sidekick [...]
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation [...]
Sanofi’s BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet
Sanofi’s BTK inhibitor flunks phase 3 autoimmune trial, delivering blow [...]
FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data
FDA slams the door in Humanigen’s face, rejects emergency use [...]
Science 37 teams up with Roche’s Foundation Medicine to boost home-based oncology trials
Science 37 teams up with Roche’s Foundation Medicine to boost [...]
As gene therapy safety faces scrutiny, Broad Institute proposes a safer and more efficient delivery tool
As gene therapy safety faces scrutiny, Broad Institute proposes a [...]
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma
BioNTech reports promising data on mRNA cocktail in mouse models [...]
Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames
Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be [...]
Insilico puts undruggable cancer targets in its crosshairs with Huadong alliance
Insilico puts undruggable cancer targets in its crosshairs with Huadong [...]